Suppr超能文献

美国 2010 年至 2015 年慢性疾病映射短式六维效用评分国家目录。

A National Catalog of Mapped Short-Form Six-Dimension Utility Scores for Chronic Conditions in the United States From 2010 to 2015.

机构信息

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.

出版信息

Value Health. 2022 Aug;25(8):1328-1335. doi: 10.1016/j.jval.2022.02.011. Epub 2022 Mar 30.

Abstract

OBJECTIVES

This study examined health preference utility weights and utility decrements associated with different types of chronic conditions in the United States.

METHODS

We used the 2010-2015 Medical Expenditure Panel Survey data for persons aged ≥ 18 years with 12-Item Short-Form Survey Physical and Mental Component Summary scores. 12-Item Short-Form Survey scores were converted to Short-Form Six-Dimension (SF-6D) preference scores to measure utilities of different chronic diseases. We used the Clinical Classification Code to identify 30 chronic diseases from 12 categories, such as cardiovascular diseases, cerebrovascular diseases, hypertension, hyperlipidemia, obesity, cancers, musculoskeletal diseases, endocrine or metabolic diseases, oral diseases, respiratory diseases, and mental disorders. A generalized linear model was used to quantify the utility decrements for 30 chronic diseases, controlling for demographic characteristics.

RESULTS

We identified 132 737 adults (mean age 47.2 years, 52.2% female, 80% white); 73% had at least one identified chronic disease, and the mean SF-6D was 0.786. Among 30 chronic diseases, the unadjusted mean SF-6D scores of patients with cognitive disorder (0.607) were the lowest, followed by congestive heart failure (0.629), rheumatoid arthritis (0.654), and lung cancer (0.662). After controlling for demographic variables (ie, age, sex) and comorbidities, cognitive disorders (-0.116), mood disorders (-0.099), rheumatoid arthritis (-0.090), liver cancer (-0.078), and stroke (-0.063) showed the highest decrements in the SF-6D scores (P < .05).

CONCLUSIONS

This study provides a nationally representative catalog of utility weights for major chronic diseases in the US general population. The utility decrements will enable researchers to calculate the health utilities of patients with multiple comorbid diseases.

摘要

目的

本研究在美国人群中考察了不同类型慢性疾病的健康偏好效用权重和效用降低情况。

方法

我们使用了 2010-2015 年医疗支出面板调查数据,纳入了年龄≥18 岁、12 项简短健康调查物理和精神成分综合评分的人群。将 12 项简短健康调查评分转换为简短六维度(SF-6D)偏好评分,以衡量不同慢性疾病的效用。我们使用临床分类代码从 12 个类别中识别出 30 种慢性疾病,如心血管疾病、脑血管疾病、高血压、高血脂、肥胖、癌症、肌肉骨骼疾病、内分泌或代谢疾病、口腔疾病、呼吸疾病和精神障碍。使用广义线性模型来量化 30 种慢性疾病的效用降低情况,控制了人口统计学特征。

结果

我们确定了 132737 名成年人(平均年龄 47.2 岁,52.2%为女性,80%为白人);73%的人至少有一种被识别出的慢性疾病,SF-6D 的平均得分是 0.786。在 30 种慢性疾病中,未经调整的认知障碍患者的 SF-6D 平均得分(0.607)最低,其次是充血性心力衰竭(0.629)、类风湿关节炎(0.654)和肺癌(0.662)。在控制了人口统计学变量(即年龄、性别)和合并症后,认知障碍(-0.116)、情绪障碍(-0.099)、类风湿关节炎(-0.090)、肝癌(-0.078)和中风(-0.063)的 SF-6D 得分降低最大(P <.05)。

结论

本研究提供了美国一般人群中主要慢性疾病效用权重的全国代表性目录。效用降低将使研究人员能够计算患有多种合并症患者的健康效用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验